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OBJECTIVES This study was performed to evaluate hemodynamic alterations of stent implantation after
Doppler flow–guided balloon angioplasty (BA).
BACKGROUND There is controversy regarding the effect of stent implantation on coronary hemodynamics
after suboptimal and optimal BA.
METHODS A total of 523 of 620 patients underwent Doppler-guided BA in the setting of a multicenter
study and were analyzed before and after additional stent implantation. Balloon angioplasty
was considered optimal when the diameter stenosis (DS) was35% and coronary flow reserve
(CFR) was2.5 and suboptimal if these two criteria were not met. Coronary flow reserve was
also measured in an angiographically normal artery to determine relative CFR. Patients were
followed for 12 months to document major adverse cardiac events (MACE).
RESULTS The main difference between patients with suboptimal BA (n  195 [51%]) and optimal BA
(n  184 [49%]) was a more pronounced increase in baseline blood flow velocity (15  8 to
22  11 vs. 14  8 to 16  10 cm/s, p  0.01). Coronary flow reserve improved after stent
implantation in both patient groups, owing to a reduction in residual lumen obstruction, as
determined by angiographic (%DS) and Doppler flow criteria (hyperemic blood flow velocity,
relative CFR), and was associated with a decrease in MACE (16% vs. 7% in optimal BA
group, p  0.08; and 27% vs. 11% in suboptimal BA group, p  0.007).
CONCLUSIONS Stent implantation enhances CFR after suboptimal and optimal Doppler-guided BA, owing
to a reduction in residual lumen obstruction—determined by angiographical and Doppler
flow criteria—as the underlying mechanism for an improved clinical outcome. (J Am Coll
Cardiol 2002;39:1513–7) © 2002 by the American College of Cardiology Foundation
The effectiveness of balloon angioplasty (BA) is hampered
by the relatively high incidence of restenosis. The introduc-
tion of stents in the beginning of the 1990s for the
treatment of procedural complications has led to a reduction
of coronary renarrowing after percutaneous transluminal
coronary angioplasty (PTCA) (1,2). The exponential
growth in the use of stent implantation has resulted in an
increasing number of patients with in-stent restenosis,
which is difficult to treat with current percutaneous tech-
niques, except for brachytherapy (3). It has been suggested
that an optimal outcome after BA is similar to the clinical
outcome of stenting (4). The results of the Doppler End-
points Balloon Angioplasty Trial Europe (DEBATE I)
study support this hypothesis (5). Patients with both a
diameter stenosis (DS) 35% and coronary flow reserve
(CFR) 2.5 after BA showed a “stent-like” clinical out-
come. Other studies confirmed these findings—that is,
optimized BA using angiography (6) or vascular ultrasound
imaging (7,8) results in a clinical outcome similar to stent
implantation. These studies suggest that a substantial num-
ber of patients fare well without stent implantation. In the
DEBATE II study, the cost-effectiveness of provisional BA,
guided by Doppler flow velocity and angiography, was
compared to that of elective stent implantation. The unique
design of this study provided the setting for a more detailed
evaluation of hemodynamic alterations after stent implan-
tation subsequent to suboptimal or optimal BA.
METHODS
Patient selection. The study group included in this suba-
nalysis consisted of 523 of 620 patients who underwent
guided BA (with angiography and Doppler flow velocity
measurements) to treat stable or unstable angina pectoris
(excluding Braunwald classification III) or documented
myocardial ischemia due to a single primary coronary
stenosis potentially amenable to stent implantation, or both,
in the setting of a multicenter study (DEBATE II). The
details of this multicenter study have been described else-
where (9). Briefly, patients scheduled for PTCA of one
major native coronary artery, with normal left ventricular
function, were included. The exclusion criteria were mul-
tivessel disease, previous Q-wave myocardial infarction in
the territory distributed by the vessel to be dilated, acute
myocardial infarction less than one week before PTCA,
total or functional coronary occlusion, lesions 25 mm in
length, extreme tortuosity of the vessel to be dilated or
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vessels that were previously bypassed or contained a throm-
bus. The study protocol was approved by the Institutional
Review Board of the participating centers. The study was
performed according to the principles in the Declaration of
Helsinki. All patients gave written, informed consent.
Angioplasty procedure and blood flow velocity assess-
ment. In the DEBATE II study, 620 patients were first
randomized to either guided BA (n  523) or direct stent
implantation (n 97). In the guided BA arm, the operators
were urged to obtain an optimal result, defined as DS35%
and CFR 2.5. A result was considered suboptimal when
these two criteria were not met (DS 35% and CFR 2.5
or DS 35% and/or CFR 2.5). This approach resulted in
bail-out stenting in 129 patients, which was allowed accord-
ing to the protocol in the presence of residual stenosis
50%; dissection type D, E or F; persistent myocardial
ischemia with dissection type C; a reduction of Thrombol-
ysis in Myocardial Infarction (TIMI) flow grade by 1; or the
existence of TIMI flow grade 0 or 1. The study group
consisted of the remaining 379 patients who underwent a
second randomization toward stent implantation or com-
pletion of the procedure. Briefly, the study protocol in-
cluded Doppler flow measurements distal to the lesion
under baseline and hyperemic conditions, using a 0.014-in.
(0.035-cm) Doppler-tipped guide wire (FloWire by En-
dosonics, Rancho Cordova, California). Maximal hyper-
emia was induced by an intracoronary bolus injection of
adenosine—12 g in the right coronary artery and 18 g in
the left coronary artery—or as an intravenous infusion (140
g/kg body weight per min).
Quantitative coronary angiography. Cine angiography
was performed after the intracoronary administration of 0.1
to 0.3 mg of nitroglycerin or 1 to 3 mg of isosorbide
dinitrate to achieve maximal coronary vasodilation. At least
two cine angiograms, in the orthogonal projections, were
obtained before coronary angioplasty and at the end of the
procedure. All cine films were analyzed by an independent
core laboratory, whose investigators had no knowledge of
the clinical or Doppler flow data. Matched views and frames
were selected for off-line quantitative computer-assisted
analysis.
Blood flow velocity analysis. During the angioplasty pro-
cedure, the Doppler flow velocity signals were recorded
continuously on videotape, using a Doppler flow spectral
analyzer (FloMap by Endosonics). The blood flow velocity
measurements were used to calculate, by means of the
time-averaged peak velocity (normalized to the cardiac
cycle), the distal blood flow velocity reserve, defined as the
ratio between the adenosine-induced hyperemic blood flow
velocity and the baseline blood flow velocity. Relative CFR
was defined as the ratio between the CFR in the target and
reference vessels. The appropriateness of the Doppler flow
measurements was verified by an independent core laboratory.
End points. Patients were followed for 12 months to
document the major adverse cardiac events (MACE), de-
fined as death from any cause, nonfatal myocardial infarc-
tion or the need for target lesion revascularization. Myocar-
dial infarction was defined as the development of a new Q
wave or a rise in serum creatine kinase, with an abnormal
plasma concentration of myocardial isoenzymes. Enzymes
were sampled twice in the first 24 h. Patients visited the
outpatient clinic 1, 6 and 12 months after hospital dis-
charge. At each visit, records were kept on the patient’s
anginal status, cardiac medications, 12-lead electrocardio-
gram and complete physical examination. No follow-up
angiogram was obtained, unless clinically indicated.
Statistical analysis. Continuous variables are expressed as
the mean value  SD. Chi-square analysis was used to
detect a difference in categorical patient characteristics. A
two-tailed unpaired t test (or Mann-Whitney U test for
nonparametric data) was used to assess differences in con-
tinuous variables. The Holms-Sidak method was performed
to control the family error rate. All relevant clinical, hemo-
dynamic and flow velocity variables were subsequently
entered in a univariate binary logistic regression analysis to
determine the predictors of CFR 2.5 after BA. Contrib-
uting factors (p  0.1) were entered into a multivariate
regression analysis to determine independency. A p value
0.05 was considered to be statistically significant.
RESULTS
A total of 523 of 620 patients who underwent guided BA in
the setting of the DEBATE II trial were included in this
subanalysis. Fifteen patients (3%) were excluded because of
technical and logistical problems. A total of 129 patients
(25%) underwent bail-out stenting. Consequently, 379 pa-
tients (73%) remained for analysis. Of these 379 patients,
184 (49%) appeared to have an optimal BA result
(DS 35% and CFR 2.5) after PTCA. A total of 195
patients (51%) did not meet these criteria. The majority of
the patients with a suboptimal BA result were characterized
by CFR 2.5 and DS 35% (n  178 [91%]), whereas 14
patients (7%) had CFR 2.5 and DS 35%, and 4 patients
(2%) had CFR 2.5 and DS 35%. The baseline charac-
teristics of both groups are depicted in Table 1. The group
of patients with an optimal result after PTCA appeared to
be younger, predominantly male and less frequently diag-
Abbreviations and Acronyms
BA  balloon angioplasty
CFR  coronary flow reserve
DEBATE  Doppler Endpoints Balloon Angioplasty
Trial Europe
DS  diameter stenosis
MACE  major adverse cardiac events
OR  odds ratio
PTCA  percutaneous transluminal coronary
angioplasty
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nosed with unstable angina pectoris, as compared with the
group of patients with a suboptimal result.
Hemodynamic, angiographic and Doppler flow variables
in the suboptimal and optimal groups before and after
BA. Heart rate was slightly higher before (70  12 vs.
67  12 beats/min, p  0.05) and after (72  12 vs. 67 
11 beats/min, p  0.05) the procedure in the patients with
a suboptimal result. In the suboptimal and optimal groups,
DS improved after guided BA, from 70  11% and 68 
11% to similar values of 23  10% and 22  8%,
respectively (Table 2). Baseline blood flow velocity increased
after BA in the suboptimal group, although it remained
unchanged in the optimal group (15 8 to 22 11 vs. 14
8 and 16  10 cm/s, respectively; p  0.01). Increased
hyperemic blood flow velocity was observed in both groups
after BA. Coronary flow reserve was already low before the
procedure in patients who showed a suboptimal result after
BA, as compared with patients with an optimal result
(1.47 0.5 vs. 1.72 0.6, p 0.01), whereas relative CFR
was equal in both patient groups. An impaired relative CFR
was observed after BA in the suboptimal group, as com-
pared with the optimal group (0.80  0.2 vs. 1.06  0.4,
p  0.01).
Hemodynamic, angiographic and Doppler flow variables
in the suboptimal and optimal BA groups after stent
implantation. Percent DS further diminished from 22 
9% to 7  8% and 22  8% to 8  8% after stent
implantation in both suboptimal and optimal groups, re-
spectively (Table 2). After stent implantation, baseline
blood flow velocity remained elevated (22 11 cm/s) in the
suboptimal group, although it remained low in the optimal
group (17 7 cm/s). Hyperemic blood flow velocity further
increased after stent implantation, to a value of 49 
26 cm/s in the suboptimal group and 52  24 cm/s in the
optimal group. In the suboptimal and optimal groups, CFR
in the target artery further improved after stent implanta-
tion, to a value of 2.36  0.7 and 3.30  0.7, respectively.
After stent implantation, relative CFR also remained low in
the suboptimal group, as compared with the optimal group
(0.95  0.3 vs. 1.12  0.4).
Univariate and multivariate analyses of predictors of
post-procedural CFR. A binary logistic regression analysis
of all relevant clinical, hemodynamic and flow velocity
variables revealed baseline CFR in the target vessel, baseline
CFR in the reference vessel, family history, male gender,
lesion length, lesion eccentricity, height, weight, age, base-
line percent DS and smoking as predictors of CFR 2.5
after PTCA. A multivariate analysis of these variables
revealed that CFR before angioplasty (odds ratio [OR] 2.32,
p  0.001), reference CFR (OR 2.59, p  0.001) and
family history (OR 2.36, p  0.002) were the only inde-
pendent predictors of CFR 2.5 directly after PTCA.
Clinical outcome in groups with an optimal or subopti-
mal result after PTCA. In Table 3, the frequencies of all
MACE are shown. The incidence of MACE at one-year
follow-up was lower in the total study group (disregarding a
Table 1. Baseline Characteristics of the 379 Study Patients
Optimal
(n  184)
Suboptimal
(n  195)
p
Value
Age (yrs) 57  10 60  11 0.001
Male 149 (81%) 136 (69%) 0.008
Systemic hypertension 62 (34%) 77 (39%) NS
Cigarette smokers 55 (30%) 51 (26%) NS
Total cholesterol 6.5 mmol/l 108 (59%) 109 (56%) NS
Diabetes mellitus 12 (7%) 21 (11%) NS
Previous myocardial infarction 15 (8%) 22 (11%) NS
Unstable angina pectoris 52 (28%) 74 (38%) 0.05
Medications
Aspirin 162 (88%) 169 (87%) NS
Beta-blocker 121 (66%) 125 (64%) NS
Calcium antagonist 92 (50%) 94 (48%) NS
Nitrates 121 (66%) 123 (63%) NS
Coronary artery dilated
LAD 96 (52%) 98 (50%) NS
RCA 57 (31%) 56 (29%) NS
LCx 31 (17%) 40 (21%) NS
CCS classification
1 7 (4%) 9 (5%) NS
2 58 (32%) 58 (30%) NS
3 48 (26%) 31 (16%) NS
4 5 (3%) 4 (2%) NS
Data are presented as the mean value SD or number (%) of patients. Values are n (%).
CCS  Canadian Cardiovascular Society; LAD  left anterior descending
coronary artery; LCx  left circumflex coronary artery; RCA  right coronary artery
Table 2. Quantitative Coronary Angiographic and Coronary
Blood Flow Velocity Data of the Patients With an Optimal and
Suboptimal Result After Balloon Angioplasty
Optimal
BA Group
(n  184)
Suboptimal
BA Group
(n  195)
p Value
Before
GBA Gain*
DS (%)
Before GBA 68  11 70  11 0.15
After GBA 22  8 23  10 0.95
After stenting 8  8 7  8 0.60
b-APV (cm/s)
Before GBA 14  8 15  8 0.49
After GBA 16  10 22  10 0.01†
After stenting 17  7 22  11 0.20
h-APV (cm/s)
Before GBA 23  15 22  12 0.21
After GBA 46  18 41  18 0.20
After stenting 52  24 49  26 0.28
CFR
Before GBA 1.72  0.6 1.47  0.5 0.01†
After GBA 3.10  0.6 1.95  0.4 0.01†
After stenting 3.30  0.7 2.36  0.7 0.56
Relative CFR
Before GBA 0.59  0.3 0.59  0.2 0.97
After GBA 1.06  0.4 0.80  0.2 0.01†
After stenting 1.12  0.4 0.95  0.3 0.11
*The upper p value is for the comparison of the gain of GBA (relative to that before
GBA) between patients with an optimal (n  184) and suboptimal (n  195) result.
The lower p value is for the comparison of the gain of stent implantation (relative to
that after GBA) between patients with an optimal (n  77) and suboptimal result
(n  110). †Statistically significant according to the Holm-Sidak method. Data are
presented as the mean value  SD.
BA  balloon angioplasty; b-APV and h-APV  baseline and hyperemic average
peak flow velocity, respectively; CFR  coronary flow reserve; DS  diameter
stenosis; GBA  guided balloon angioplasty.
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suboptimal or optimal result) with stent implantation in
addition to guided BA, as compared with patients who
underwent BA only (9% vs. 21%, p 0.002). The incidence
of MACE in the suboptimal group that had stent implan-
tation in addition to guided BA was 11%, as compared with
27% in patients who had guided BA only (p  0.007). A
similar trend was seen in the patients with an optimal result
after PTCA (7% vs. 16%, p  0.08).
DISCUSSION
The results of this analysis of the DEBATE II study
demonstrate that the clinical benefit of stent implantation
after suboptimal and optimal BA is related to a reduction in
residual lumen obstruction, as determined by angiographic
and Doppler flow indexes.
Suboptimal guided BA and additional stent implanta-
tion. The unique design of the DEBATE II study allowed
the evaluation of the effect of stent implantation after BA on
coronary hemodynamics in a large number of patients. The
data show that a suboptimal result of BA, defined by
angiographic and Doppler flow criteria, is due to both an
enhanced baseline blood flow velocity and, presumably,
residual lumen obstruction, as reflected by impaired relative
CFR, as compared with an optimal result after BA. In the
group of patients who did not meet the criteria for optimal
BA, baseline blood flow velocity appeared to be elevated
after the procedure, which confirms earlier studies (10–12).
Coronary flow reserve was already impaired before PTCA
in the subgroup of patients with a suboptimal result directly
after PTCA, along with a normal relative CFR (and an
equal degree of angiographic severity of epicardial stenosis
in both groups). Moreover, multivariate analysis showed
that CFR before the intervention and reference CFR were
predictors of CFR after PTCA, suggesting that hemody-
namic factors before the intervention are responsible for the
impaired CFR after PTCA, rather than procedure-related
factors, such as particulate embolization and reactive epi-
cardial vasoconstriction at the site of the guide wire tip
(13,14). Several other mechanisms have been suggested to
explain an impaired CFR, due to an enhanced baseline flow
velocity directly after guided BA, including a temporarily
disturbed autoregulation, microvascular stunning and dif-
fuse disease, as reported in previous studies (10–12,15). The
baseline flow velocity remained unchanged after stent im-
plantation, whereas CFR improved, owing to a reduction in
residual lumen obstruction, as determined by angiographic
(diminished %DS) and Doppler (enhanced hyperemic
blood flow velocity and relative CFR) criteria. This im-
proved hemodynamic status after stent implantation was
associated with an improved clinical outcome, as reported
before (9).
Optimal guided BA and additional stent implantation.
An optimal result after BA was achieved in approximately
half of the patients. These patients were characterized by a
baseline blood flow velocity that remained unchanged after
guided BA, whereas the hyperemic blood flow velocity
increased significantly as a result of the diminished residual
lumen obstruction. This optimal result after BA led to a low
incidence of MACE (16%) during follow-up, which is in
accordance with DEBATE I, the Doppler Endpoint Stent-
ing Interventional Investigation (DESTINI) and the
French Randomized Optimal Stenting Trial (FROST).
This indicates that potentially half of the patients show a
good clinical outcome after optimal BA (incidence of
MACE varying between 15% and 19%). This treatment
strategy, to avoid additional stent implantation, prevents the
risk of the patient developing in-stent restenosis, which is
currently still difficult to treat (5,16,17). Nevertheless, ad-
ditional stent implantation in this subgroup of patients
resulted in a further increase in CFR and relative CFR,
owing to an enhancement of hyperemic blood flow velocity.
The incidence of MACE in the group of patients with
additional stent implantation after optimal BA was 7%,
whereas that in patients who had primary stent implantation
in the main study was 13% (p  0.08). This trend toward
significance suggests that physiologically guided stent im-
plantation, either based on intracoronary blood flow velocity
or pressure measurements (18), may be better than primary
stent implantation. However, this hypothesis should be
tested in a larger group of patients. Furthermore, it should
be noted that the excellent clinical outcome after Doppler-
guided stent implantation could also be related to a selection
bias of the study patients, consisting predominantly of
patients with single-vessel disease and those with a presum-
ably normal or mildly diseased microvasculature.
Study limitations. This study is a post-hoc analysis of a
multicenter study. The changes in arterial dimensions were
assessed by quantitative coronary angiography; intravascular
ultrasound imaging was not mandatory for appropriate
evaluation of epicardial remodeling, estimation of coronary
volume flow changes or shear stress analysis. Furthermore, a
substantial number of patients were excluded from this
analysis because of bail-out stent implantation. Finally, this
study involved a selected cohort of patients with single-
vessel disease and normal left ventricular function, thus
limiting the extrapolation of the present findings to other
patient groups.
Clinical implications. The operators pursued an aggressive
approach to obtain an optimal angiographic result, as
Table 3. Frequency of Major Adverse Cardiac Events
Optimal
BA Group
(n  184)
Suboptimal
BA Group
(n  195)
BA
(n  107)
Stenting
(n  77)
BA
(n  85)
Stenting
(n  110)
Death 1 (0.9%) 2 (2.6%) 2 (2.3%) 1 (0.9%)
Myocardial infarction 2 (1.8%) 0 3 (3.5%) 4 (3.6%)
TLR rate 14 (13%) 3 (4) 18 (21%) 7 (6.3%)
Total MACE 17 (16%) 5 (6.5%) 23 (27%) 12 (11%)
Data are presented as the number (%) of patients.
BA  balloon angioplasty; MACE  major adverse cardiac events; TLR  target
lesion revascularization.
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demonstrated by the percent DS after BA. The present
study shows that intracoronary hemodynamic guidance of a
coronary intervention, in addition to angiography, results in
an additional improvement in the patient’s clinical outcome.
Approximately 50% of the patients in the provisional
stenting arm of the DEBATE II study showed an unsatis-
factory result, despite Doppler-guided BA, which is in
accordance with the DESTINI and FROST trials. This
subset of patients requires stent implantation to improve the
direct hemodynamic and late clinical outcomes. However,
this indicates that the remaining 50% of the patients showed
a good “stent-like” clinical outcome after optimal BA. From
a clinical point of view, this is an essential observation,
because a restenotic lesion can be treated easily with a stent,
whereas the treatment of in-stent restenosis is still cumber-
some (3). The provocative low rate of target lesion revascu-
larization in the subgroup of patients with an optimal result
after BA, followed by additional stent implantation, sug-
gests the usefulness of hemodynamic guidance of stent
implantation, which is in contrast to the current clinical
practice of direct stenting.
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